Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer. Licata L, Mariani M, Chiavassa A, Partridge AH, et al. Ann Oncol 2026 Sep 17:S0923-7534(26)06645-7. doi: 10.1016/j.annonc.2026.

Read + Share

Amedeo Smart

Independent Medical Education

Licata L, Mariani M, Chiavassa A, Partridge AH, et al. Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer. Ann Oncol 2026 Sep 17:S0923-7534(26)06645-7. doi: 10.1016/j.annonc.2026.
PMID: 42754095